BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 11/24/2014 10:45:17 AM
Sarepta Therapeutics (SRPT) Announces First Patient Dosed In Confirmatory Study Of Eteplirsen In Ambulant Patients With Duchenne Muscular Dystrophy 11/18/2014 9:21:35 AM
Sarepta Therapeutics (SRPT) Announces First Patient Dosed In Study Of Eteplirsen In Non-Ambulant Patients With Duchenne Muscular Dystrophy 11/13/2014 10:56:57 AM
Sarepta Therapeutics (SRPT) Announces Third Quarter 2014 Financial Results and Recent Corporate Developments 11/6/2014 1:37:54 PM
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 11/4/2014 9:59:31 AM
Sarepta Therapeutics (SRPT) To Announce Third Quarter 2014 Financial Results And Corporate Update On November 6, 2014 11/3/2014 9:50:24 AM
The Reasons Why Garabedian Remains The Best CEO To Head Sarepta Therapeutics (SRPT) 10/30/2014 6:16:56 AM
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay 10/27/2014 3:43:08 PM
Is Sarepta Therapeutics (SRPT) Short Of Cash? 10/27/2014 8:12:50 AM
Sarepta Therapeutics (SRPT) Tanks As FDA Seeks Further Data On Eteplirsen; Stock Down 32.47% At Market Close (Oct. 27, 2014) 10/27/2014 6:22:38 AM
12345678910...